DINO expression is silenced by DNA methylation in human cancers that retain wild-type p53, suggesting a model whereby the silencing of DINO expression represents an alternative mechanism that can lead to the loss of p53 tumor suppressor activity [105]. The gene discussed is DINOL; the disease is cancer.